Shift in the epidemiology of pertussis infection: An indication for pertussis vaccine boosters for adults?

Drugs

Volumn 66, Issue 6, 2006, Pages 731-741

  Yeh, Sylvia H ^a,b,c   Mink, ChrisAnna M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MILLER CHILDREN S HOSPITAL   (United States)

^c Liu Research Building   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; PERTUSSIS VACCINE; VIRULENCE FACTOR;

BLEEDING; BORDETELLA PERTUSSIS; BRAIN DISEASE; CLINICAL FEATURE; COST BENEFIT ANALYSIS; COST OF ILLNESS; COUGHING; DEVELOPING COUNTRY; DISEASE CONTROL; DISEASE TRANSMISSION; EPIDEMIC; GRAM NEGATIVE BACTERIUM; HUMAN; INGUINAL HERNIA; JAPAN; PATHOGENESIS; PERTUSSIS; PETECHIA; PNEUMONIA; PNEUMOTHORAX; RECTUM PROLAPSE; REVIEW; SEIZURE; SEROPREVALENCE; SINUSITIS; SUBCUTANEOUS EMPHYSEMA; UMBILICAL HERNIA; UNITED STATES; URINE INCONTINENCE; VACCINATION;

ADOLESCENT; ADULT; AGED; AUSTRALIA; BORDETELLA PERTUSSIS; CANADA; CHILD; CHILD, PRESCHOOL; FRANCE; HEALTH PLAN IMPLEMENTATION; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; INFANT; MIDDLE AGED; PERTUSSIS VACCINE; UNITED STATES; VACCINES, ACELLULAR; WHOOPING COUGH;

BORDETELLA PERTUSSIS;

EID: 33646783688     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200666060-00001     Document Type: Review

References (66)

1. Cherry JD, Heininger U. Pertussis and other Bordetella infections. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. 4th ed. Philadelphia (PA): WB Saunders Company, 1998: 1423-40
2. Laring JS, Hay M. Whooping-cough: its prevalence and mortality in Aberdeen. Public Health 1902; 14: 584-98
3. Mannerstedt G. Pertussis in adults. J Pediatr 1934; 5: 596-600
4. Brennan M, Strebel P, George H, et al. Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis. J Infect Dis 2000; 181: 210-5
5. Gehanno JF, Pestel-Caron M, Nouvellon M, et al. Nosocomial pertussis in healthcare workers from a pediatric emergency unit in France. Infect Control Hosp Epidemiol 1999; 20: 549-52
6. Centers for Disease Control and Prevention. Pertussis outbreak - Vermont 1996. MMWR 1997; 46: 8226
7. de Melker HE, Conyn-van Spaendonck MAE, Rumke HC, et al. Pertussis in the Netherlands: an outbreak despite high levels of immunization with whole cell vaccine. Emerg Infect Dis 1997; 3: 175-8
8. Klement E, Uliel L, Engel I, et al. An outbreak of pertussis among young Israeli soldiers. Epidemiol Infect 2003; 131: 1049-54
9. van der Zee A, Mooi F, van Enbden J, et al. Molecular evolution and host adaptation of Bordetella spp: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J Bacteriol 1997; 179: 6609-17
10. Heininger U, Stehr K, Schmitt-Grohe S, et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994; 13: 306-9
11. Hewlett EL. A commentary on the pathogenesis of pertussis. Clin Infect Dis 1999; 28 Suppl. 2: S94-8
12. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005; 5: S10-18
13. Edwards KM, Decker MD, Mortimer EA. Pertussis vaccine. In: Plotkin SA, Orenstein WA, editors. Vaccines. 3rd ed. Philadelphia (PA): WB Saunders Company, 1999: 293-344
14. Bass JW, Stephenson SR. The return of pertussis. Pediatr Infect Dis 1978; 6: 141-4
15. Mertsola J, Ruuskanen O, Eerola E, et al. Intrafamilial spread of pertussis. J Pediatr 1983; 103: 359-63
16. Cherry JD. The epidemiology of pertussis and pertussis immunization on in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr 1984; 14: 1-78
17. Centers for Disease Control and Prevention. Pertussis: United States, January 1992-June 1995. MMWR 1995; 44: 525-9
18. Centers for Diseases Control and Prevention. Pertussis -United States, 1997-2002. MMWR 2002; 51 (04): 73-6
19. Health Canada, Population and Public Health Branco. Notifiable disease on-line, 1986-1998 [online]. Available from URL: http: //cutjera/oc/gc/ca/dsol/ ndis/c-age_e.html [Accessed 2005 Jan 24]
20. Andrews R, Herceg A, Toberts C. Pertussis notifications in Australia 1991 to 1997. Commun Dis Intell 1997; 21: 145-8
21. World Health Organization. WHO vaccine-preventable diseases: monitoring system 2004 global summary [online]. Available from URL: http: //www.who.int/vaccines-documents/GlobalSummary/GlobalSummary.pdf [Accessed 2005 Jan 24]
22. Murphy T, Bisgard K, Sanden G. Diagnosis and laboratory methods. In: Guidelines for the control of pertussis outbreaks. Atlanta (GA): Centers for Disease Control and Prevention, 2000
23. Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353: 1555-63
24. Kosters K, Riffelmann M, Wirsing von Konig CH. Evaluation of a real-time PCR assay for detection of Bordetella pertussis and B. parapertussis in clinical samples. J Med Microbiol 2001; 50: 436-40
25. Riffelmann M, Wirsing von Konig CH, Caro V, et al. Nucleic acid amplification tests for diagnosis of Bordetella infections. J Clin Microbiol 2005; 43: 4925-9
26. Marchant CD, Loughlin AM, Lett SM, et al. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis 1994; 169: 1297-305
27. Baughman AL, Bisgard KM, Edwards KM, et al. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin Diagn Lab Immunol 2004; 11: 1045-53
28. Cattaneo LA, Reed GW, Haase DH, et al. The seroepidemiology of Bordetella pertussis infection: a study of persons ages 1-65. J Infect Dis 1996; 173: 1256-9
29. Cromer BA, Goydos J, Hackell J, et al. Unrecognized pertussis infections in adolescents. Am J Dis Child 1993; 147: 575-7
30. Wright SW, Edwards KM, Decker MD, et al. Pertussis seroprevalence in Emergency Department staff. Ann Emerg Med 1994; 21: 413-7
31. Nennig ME, Shinefield HR, Edwards KM, et al. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275: 1672-4
32. Yih WK, Lett SM, de Vignes FN, et al. The increasing incidence of pertussis in Massachusetts adolescents and adults 1989-1998. J Infect Dis 2000; 182: 1409-16
33. Wright SW, Decker MD, Edwards KM. Incidence of pertussis infection in healthcare workers. Infect Control Hosp Epidemiol 1999; 20: 120-3
34. Mink CM, Cherry JD, Christ PD, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992; 14: 464-71
35. Wright SW, Edwards KK, Decker MD, et al. Pertussis infection in adults with persistent cough. JAMA 1995; 273: 1044-6
36. Rosenthal S, Stebel P, Cassiday P, et al. Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis 1995; 171: 1650-2
37. Jansen DL, Gray GC, Putman SD, et al. Evaluation of pertussis in US Marine corp trainees. Clin Infect Dis 1997; 25: 1099-107
38. Senzilet LD, Halperin SA, Spika JS, et al. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 32: 1691-87
39. Roberson PW, Goldberg H, Jarvie BH, et al. Bordetella pertussis infection: a cause of persistent cough in adults. Med J Aust 1987; 146: 522-5
40. Gilberg S, Njamkepo E, Parent du Cĥatelet I, et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 2002; 186: 415-8
41. Davis J. Clinical and economic effects of pertussis outbreaks. Pediatr Infect Dis J 2005 Jun; 24 (6 Suppl.): S109-16
42. Centers for Disease Control and Prevention National Immunization Program. Record of the meeting of the Advisory Committee on Immunization Practices, 2005 Feb 10-11 [online]. Available from URL: http: //www.cdc.gov/nip/ACIP/minutes/ acip-min-feb05.pdf [Accessed 2006 Mar 23]
43. Mortimer EA. Pertussis and its prevention: a family affair. J Infect Dis 1990; 161: 473-9
44. Valenti WM, Pincus PH, Messner MK. Nosocomial pertussis: possible spread by a hospital visitor. Am J Dis Child 1980; 134: 520-7
45. Beiter A, Lewis K, Pineda EF, et al. Unrecognized maternal peripartum pertussis with subsequent fatal neonatal pertussis. Obstet Gynecol 1993; 82: 691-3
46. Deen JL, Mink CM, Cherry JD, et al. A household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21: 1211-9
47. Bisgard KM, Pascaul FB, Ehresmann KR, et al. Infant pertussis, who was the source? Pediatr Infect Dis J 2004; 23: 985-9
48. Crowcroft NS, Booy R, Harrison T, et al. Severe and unrecognized pertussis in UK infants. Arch Dis Child 2003; 88: 202-6
49. Grimpel E, Baron S, Levy-Bruhl D, et al. Influence of vaccination coverage on pertussis transmission in France. Lancet 1999; 345: 1699-700
50. Schmitt-Grohe S, Cherry JD, Heininger U, et al. Pertussis in German adults. Clin Infect Dis 1995; 21: 860-6
51. Maclean DW. Adults with pertussis. J R Coll Gen Pract 1982; 32: 298-300
52. Aoyama T, Takeuchi Y, Goto A, et al. Pertussis in adults. Am J Dis Child 1992; 146: 163-6
53. Edward R, Edwards K. Health burden of pertussis in adolescents and adults. Pediatr Infect Dis J 2005; 5: s44-7
54. Long SS, Welkon CI, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990; 161: 480-6
55. Halperin SA, Wang EEL, Law B, et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT). Clin Infect Dis 1999; 28 (6): 1238-43
56. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182: 174-9
57. Lee LH, Pichichero ME. Costs of illness due to Bordetella pertussis in families. Arch Fam Med 2000; 9: 989-96
58. Purdy KW, Hay JW, Botteman MF, et al. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis. Clin Infect Dis 2004; 39: 20-8
59. Calugar A, Ortega-Śanchez I, Tiwari T, et al. Nosocomial pertussis: cost of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006; 42: 981-8
60. FDA. Product approval information: BOOSTRIX™ licensing action [online]. Available from URL: http: //www.fda.gov/cber/products/tdapgla050305. htm [Accessed 2006 Mar 23]
61. FDA. Product approval information: ADACEL™ licensing action.... [online]. Available from URL: http: //www.fda.gov/cber/products/tdapave061005. htm [Accessed 2006 Mar 23]
62. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulation of five new strategies. Vaccine 2004; 22: 3154-65
63. Lee GM, LeBaron C, Murphy TV, et al. Pertussis in adolescents and adults: should we vaccinate? Pediatrics 2005; 115: 1675-84
64. Iskedjian M, Walker JH, Hemels ME. Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada. Vaccine 2004; 22: 4215-27
65. Scuffham PA, McIntyre PB. Pertussis vaccination strategies for neonates: an exploratory cost-effectiveness analysis. Vaccine 2004; 22: 2953-64
66. Hethcote HW, Horby P, McIntyre P. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine 2004; 22: 2181-91